Related Experiment Video

Updated: Mar 25, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.2K

[Impact of guideline adherence on mortality in treatment of left heart failure]

S Neubauer1, T Schilling2, J Zeidler3

  • 1Leibniz Universität Hannover, Center for Health Economics Research Hannover (CHERH), Hannover, Deutschland. sn@cherh.de.

Herz
|February 18, 2016
PubMed

Insights

Adherence to German chronic heart failure guidelines significantly reduces patient mortality. Following recommendations for medications like ACE inhibitors and beta-blockers, along with regular echocardiography, improves outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • German national guidelines for chronic heart failure (CHF) offer evidence-based treatment recommendations.
  • The extent of guideline implementation in routine practice and its impact on mortality remain unclear.

Purpose of the Study:

  • To assess the adherence to CHF guidelines in routine care.
  • To determine the effect of guideline adherence on patient mortality.

Main Methods:

  • Analysis of 4-year claims data from a major German health insurance fund.
  • Inclusion of 85,465 heart failure patients.
  • Binary logistic and Cox regression analyses to examine factors influencing mortality, including drug prescriptions, diagnostic measures, vaccination, and New York Heart Association (NYHA) status.

Main Results:

  • Approximately 60% of medications were prescribed according to guidelines.
  • Higher NYHA status correlated with increased mortality (OR 3.264).
  • Guideline-adherent pharmacotherapy (ACE inhibitors, beta-blockers) and regular echocardiography were associated with significantly lower mortality rates (ORs 0.448, 0.444, and 0.314, respectively).

Conclusions:

  • Guideline-adherent therapy demonstrably impacts mortality in heart failure patients, confirming clinical trial findings.
  • Analysis of claims data provides evidence that adherence to CHF guideline recommendations improves clinical outcomes.
Abstract

Keywords:
Claims dataGuideline adherenceHeart failureMortalityPharmacotherapy

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.2K
Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.8K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
537
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
512
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
503
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
684
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K